Clinical Trial Update: Single-dose, Study of RBP-6000 in Opioid Dependent Individuals [Phase 1]

View source ↗

Summary

Phase 1 single-dose study of RBP-6000 for opioid use disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• RBP-6000 (buprenorphine)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED